About Hermab 440mg injection
Hermab 440mg Injection contains Trastuzumab, a targeted therapy used for the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric cancer. HER2-positive cancers produce excessive amounts of the HER2 protein, which promotes the rapid growth and spread of cancer cells. Trastuzumab works by specifically targeting these HER2 receptors, helping to block cancer cell growth and improve treatment outcomes. As HER2-positive breast cancer is often more aggressive than other breast cancer types, targeted therapies such as Hermab 440mg Injection play a crucial role in cancer management. Patients are advised to use effective contraception during treatment and for at least seven months after receiving the final dose to prevent pregnancy-related risks. This medication is not recommended for individuals under 18 years of age, patients with severe breathing difficulties, or those requiring oxygen therapy. Before starting treatment, patients should inform their doctor about any history of heart disease, breathing problems, previous cancer treatments, or any medicines, supplements, and herbal products they are currently taking. Regular monitoring during treatment may help ensure the safe and effective use of Hermab 440mg Injection while minimizing potential side effects and complications.
Targeted Therapy for Advanced Breast CancerHermab 440mg injection, with its active compound Trastuzumab, represents a significant advancement in targeted cancer therapy. Intended for patients diagnosed with advanced and metastatic breast cancer, this medication specifically attacks cancer cells that overexpress the HER2 protein. Its high efficacy in challenging cancer cases makes it a vital tool in modern oncology treatment plans.
Safe Packaging and Optimal StorageEach Hermab 440mg injection is professionally packaged in a single-dose box to maintain purity and dosage accuracy. The medicine should be stored in a dry place to preserve its quality and effectiveness. The well-planned packaging ensures convenience for healthcare professionals as well as safety for patients receiving the treatment.
FAQ's of Hermab 440mg injection:
Q: How does Hermab 440mg injection work in treating breast cancer?
A: Hermab 440mg injection contains Trastuzumab, which targets the HER2 protein on breast cancer cells. By binding to this protein, the medication inhibits the growth and spread of cancer, making it effective for advanced and metastatic breast cancer cases.
Q: What is the recommended usage of Hermab 440mg injection?
A: Usage and dosage of Hermab 440mg injection should always be determined by a healthcare professional. It is typically administered intravenously in a clinical setting, following guidelines specific to the patient's condition and treatment plan.
Q: When should the Hermab 440mg injection be administered during treatment?
A: Hermab 440mg injection is usually given according to a schedule recommended by your oncologist, often in regular cycles as part of a larger treatment regimen for advanced or metastatic breast cancer.
Q: Where should Hermab 440mg injection be stored before use?
A: The injection should be kept in a dry place, away from moisture and direct sunlight, to maintain its efficacy and stability until its expiration date in 2028.
Q: What are the benefits of using Hermab 440mg in breast cancer treatment?
A: Hermab 440mg is designed to improve treatment outcomes for patients with HER2-positive advanced or metastatic breast cancer, offering targeted action with a proven safety profile under medical supervision.
Q: Who supplies Hermab 440mg injection and where is it exported from?
A: Hermab 440mg is supplied, traded, and exported by companies based in India, ensuring reliable distribution both within the country and globally for patients in need.